Future Directions in the Treatment of Patients With HER2+ Breast Cancer: What Community Oncologists Need to Know
Repurposing Therapies for Treatment of HER2 Amplified Pancreatic Cancer - Cowley Mark
A Phase Ib/II Trial of Trastuzumab-DM1 (T-DM1) with Pertuzumab for Women with HER2-Positive Locally-Advanced or Metastatic Breast Cancer who were Previously.
New Evidence reports on presentations given at ASCO 2012 New Targeted Agents Demonstrate Greater Efficacy and Tolerability in the Treatment of HER2-positive.
Copyright © 2010, Research To Practice, All rights reserved. Part VI: HER2-Positive Gastric Cancer Monday, October 25, 2010 7:30 PM - 8:30 PM ET Monday.
